| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
383,180,000 |
| Market
Cap: |
3.06(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.255 - $6.41 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ImmunityBio is a clinical-stage biotechnology company developing therapies and vaccines that complement, harness, and amplify the immune system to defeat cancers and infectious diseases. Co.'s platforms include: antibody cytokine fusion proteins, which include Anktiva, a class of biopharmaceuticals that enhance the therapeutic potential of cytokines, and promote lymphocyte infiltration at a site of disease, improving immune response; and DNA, RNA, and recombinant protein vaccine technologies, which are for infectious diseases to target viruses, including SARS-CoV-2, and for oncology to deliver common tumor-associated antigens, and neoepitopes (expressed only by cancer cells).
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
103,915 |
103,915 |
| Total Buy Value |
$0 |
$0 |
$289,093 |
$289,093 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Adcock Richard |
CEO & President |
• • – |
2024-02-05 |
4 |
D |
$4.04 |
$174,387 |
D/D |
(43,165) |
243,138 |
|
- |
|
| Adcock Richard |
CEO & President |
• • – |
2024-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
83,334 |
286,303 |
|
- |
|
| Simon Barry J. |
Director |
– • – |
2024-01-31 |
4 |
D |
$3.36 |
$74,236 |
D/D |
(22,094) |
3,123,761 |
|
- |
|
| Simon Barry J. |
Director |
– • – |
2024-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,200 |
3,145,855 |
|
- |
|
| Sachs David C. |
Chief Financial Officer |
• – – |
2024-01-31 |
4 |
D |
$3.36 |
$90,166 |
D/D |
(26,835) |
185,838 |
|
- |
|
| Sachs David C. |
Chief Financial Officer |
• – – |
2024-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
70,745 |
212,673 |
|
- |
|
| Gallagher Regan J |
Chief Accounting Officer |
• – – |
2024-01-31 |
4 |
D |
$3.36 |
$45,259 |
D/D |
(13,470) |
94,334 |
|
- |
|
| Gallagher Regan J |
Chief Accounting Officer |
• – – |
2024-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,872 |
107,804 |
|
- |
|
| Adcock Richard |
CEO & President |
• • – |
2023-12-31 |
4 |
D |
$5.02 |
$85,822 |
D/D |
(17,096) |
202,969 |
|
- |
|
| Adcock Richard |
CEO & President |
• • – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,483 |
220,065 |
|
- |
|
| Sachs David C. |
Chief Financial Officer |
• – – |
2023-12-31 |
4 |
D |
$5.02 |
$52,765 |
D/D |
(10,511) |
141,928 |
|
- |
|
| Sachs David C. |
Chief Financial Officer |
• – – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,397 |
152,439 |
|
- |
|
| Gallagher Regan J |
Chief Accounting Officer |
• – – |
2023-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,030 |
74,932 |
|
- |
|
| Nant Capital, Llc |
See remarks |
– – • |
2023-09-11 |
4 |
A |
$1.29 |
$269,986,597 |
I/I |
209,291,936 |
32,606,985 |
|
- |
|
| Simon Barry J. |
Director |
– • – |
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,199 |
3,088,655 |
|
- |
|
| Gallagher Regan J |
Chief Accounting Officer |
• – – |
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,872 |
53,902 |
|
- |
|
| Sachs David C. |
Chief Financial Officer |
• – – |
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
70,744 |
122,042 |
|
- |
|
| Gallagher Regan J |
Chief Accounting Officer |
• – – |
2023-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,030 |
21,030 |
|
- |
|
| Blaszyk Michael D |
Director |
– • – |
2023-06-05 |
4 |
B |
$2.72 |
$198,023 |
I/I |
71,915 |
71,915 |
2.1 |
-54% |
|
| Brennan John Owen |
Director |
– • – |
2023-06-02 |
4 |
B |
$2.74 |
$70,700 |
D/D |
25,000 |
25,000 |
2.39 |
-51% |
|
| Clark Wesley |
Director |
– • – |
2023-06-01 |
4 |
B |
$2.91 |
$20,370 |
D/D |
7,000 |
8,000 |
2.39 |
-51% |
|
| Adcock Richard |
CEO & President |
• • – |
2023-02-05 |
4 |
D |
$4.33 |
$182,691 |
D/D |
(42,192) |
185,582 |
|
- |
|
| Adcock Richard |
CEO & President |
• • – |
2023-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
83,333 |
227,774 |
|
- |
|
| Sachs David C. |
Chief Financial Officer |
• – – |
2022-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,598 |
51,298 |
|
- |
|
| Adcock Richard |
CEO & President |
• • – |
2022-12-31 |
4 |
D |
$5.07 |
$21,664 |
D/D |
(4,273) |
144,441 |
|
- |
|
195 Records found
|
|
Page 1 of 8 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
1.00 (11.12%) 
